We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

December 17, 2021

A Year in Review: Top 10 Things We Saw and Did in 2021

Commentary
Sophie Madden and Meaghan Schedel
&

This was a booming year of growth in the world of digital health, with first of their kind investments, acquisitions and product launches. We’ve captured the top 10 things we saw and did in our 2021 year in review. 


What we saw: 


1. COVID-19 impacted digital health adoption and ROI in a positive way 

At the start of 2021 we predicted Health @ Home would be the future, shifting patient care away from the traditional hospital setting. Our community insights echoed this with 67% of those polled investing and partnering more, 22% investing and partnering more conservatively, and only 11% believing there were bigger concerns than investing in digital health.


2. Pharma- DTx partnerships tended to be ‘’combination’’ DTx 

While in recent years we’ve seen pharma start to embrace standalone DTx, this past year most new DTx partnerships (87.5%) focused on digital companions. In terms of therapeutic areas, metabolic (diabetes) was the most popular. 


3. Big Tech saw the challenges of being in healthcare

The same week that Google dismantled its Health Division, Apple announced it was scaling back their app project, Health Habit. The retreat shows the challenges Big Tech faces in entering the complex and fragmented healthcare system and the need to possibly change their approach. 


4. Slow uptake of DiGA leads to question of the model’s sustainability 

With the first 10 DiGAs introduced in 2020, we saw the library add an additional 15 solutions in 2021. While some countries, like France, are adopting DiGA-like models, others say approval (25 apps) and prescription numbers (50,000) in Germany are still too low to show success and sustainability at this stage. 


5. 2021 was the year for mental health apps, mergers and acquisitions 

There’s been a rise in attention to mental health as a result of COVID-19, with digital health being well positioned to support growing needs. We saw a flurry of activity in this space, including Amwell acquiring Silvercloud Health, Headspace and ginger.io merging to form Headspace Health, and Woebot receiving FDA breakthrough designation for their postpartum depression prescription digital therapeutic.



What we did at HealthXL:


1. We hosted over 178 virtual meetings, 2 in person Global Gatherings and 2 Cross-Industry Working Groups

HealthXL’s virtual meetings offered a chance for community members to connect at a time when in person meetings were at a standstill. We discussed the future of digital health, solutions to key challenges in the space, and the evolving landscape. Our Global Gatherings in Boston and Dublin this fall brought together innovators and global leaders from all areas of digital health. HealthXL also hosted a pre-competitive cross-industry working group that convened to create an open-source guidance to facilitate digital health vendor assessment for clinical trials and a working group on the future of skin health.


2. We got deeper in DTx

This past year we published two reports diving into the areas of Prescription Digital Therapeutics and DTx routes to market. Check out our PDT report and Part I of the DTx routes to market report now and keep an eye out for Part II coming in January!  


3. We launched an App and 5 new HealthXL Communities 

The HealthXL app brings news, networking and meetings to your fingertips. The HealthXL app is now available for Android and iOS. Our communities allow experts to get the latest news and curated insights from the HealthXL team while connecting with their peers on key areas of interest. Our DTx community has over 130 active members with our Telemedicine & Virtual Care, Clinical Trials Innovation, Digital Mental Health & Neurology, and The Future of Skin Health communities growing daily.  


4. We grew by 32% this past year
We were delighted to welcome new HealthXL members across all of our teams this year. We plan to continue to grow in 2022 and have already published several job postings. Interested in joining our team? Check here

5. We added new products to our Advisory offerings
We’ve been providing expert insights and perspectives to our clients for over eight years with a focus on bringing together the people and insights to solve some of the industry’s biggest challenges, and helping them evolve their digital health programs. This past year we added Ideation Workshops and Opportunity and Trends Assessments, among others to our portfolio of offerings. Some of our most popular offerings are Market Landscape Analysis and Bespoke Digital Health Workgroups. Interested in learning more? Reach out here


And that’s a wrap on 2021! This will be our last blog of the year as we begin to wind down for the holidays. Our offices will be closed from December 27th - January 3rd but we look forward to reconnecting with you all in the new year! 


We’ll be starting the year off with a blog on our top 5 predictions for 2022 and our first in-person event of the year in Basel on February 24th. We can’t wait to see you there! 


Until then, from all of us at HealthXL, happy holidays, and here's to a brighter 2022!



We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: DTx last mile delivery: HCPs and Patient adoption (Part 2)

3rd February @ 10:45AM EDT

Are you struggling getting HCPs and/or patients to adopt your DTx products? Keep reading, this sprint is for you! Places are limited so apply now to join the second session of this series and discuss with other senior leaders, DTx last mile delivery.

Featuring
Katie Archer
Katie Archer
Director, Health & Welfare Benefits Design, Planning and Analysis at The Hartford
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Featuring
Katie Archer
Katie Archer
Director, Health & Welfare Benefits Design, Planning and Analysis at The Hartford
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: The Regulation of SaMD in the US

14th February @ 10:45AM EDT

Join us in this US-focused Masterclass led by Clay Anselmo and Bernhard Kappe, As they walk us through the regulation of SaMD in the US. Apply now to secure your place.

Featuring
Bernhard Kappe
Bernhard Kappe
Founder & CEO, Orthogonal
Clay Anselmo
Clay Anselmo
VP Quality Assurance and Regulatory Affairs, ENvizion
Featuring
Bernhard Kappe
Bernhard Kappe
Founder & CEO, Orthogonal
Clay Anselmo
Clay Anselmo
VP Quality Assurance and Regulatory Affairs, ENvizion
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx - Pharma partnerships

15th February @ 10:45AM EDT

Join us as we deep dive into DTx-Pharma partnerships, with a focus on how to monetize DTx within the traditional pharmaceutical business model. Apply now to connect with peers and hear from thought leaders in this space.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Mansa Shroff
Mansa Shroff
Head of Partnerships at WKD.SMRT
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Mansa Shroff
Mansa Shroff
Head of Partnerships at WKD.SMRT
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Webinar: DTx commercialisation models - Pharma Partnerships & D2C route

17th February @ 10:00AM EDT

Last month, we did a deep dive on the Employer route to market for DTx products. Join us this month as we look into other potential go-to-market strategies for Digital Therapeutics. Apply now to hear valuable insights from thought leaders in this space.

Featuring
Pierre Leurent
Pierre Leurent
CEO, Voluntis
Mette Dyhrberg
Mette Dyhrberg
Founder & CEO, Mymee
Featuring
Pierre Leurent
Pierre Leurent
CEO, Voluntis
Mette Dyhrberg
Mette Dyhrberg
Founder & CEO, Mymee

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation

Masterclass: Clinical Trials Design for Digital Health products

31st January @ 10:45AM EDT

Join us in this Masterclass led by Click Therapeutics, as we discuss Clinical Trials Design for Digital Health Products. Our Masterclass sessions are the perfect opportunity to hear from thought leaders in the space and share your own thoughts and experiences.

Featuring
Shaheen Lakhan
Shaheen Lakhan
Chief Medical Officer , Click Therapeutics
Featuring
Shaheen Lakhan
Shaheen Lakhan
Chief Medical Officer , Click Therapeutics
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation

Digital tech for Trial Recruitment and Retention

2nd February @ 10:45AM EDT

Join our Digital Health Meeting led by Laura Gunn from Pharmstars as we discuss digital tech for Trial Recruitment and Retention. This is the perfect opportunity to connect with peers and meet new people working in this space.

Featuring
Laura Gunn
Laura Gunn
Managing Director at PharmStars
George Platings
George Platings
Market Development Specialist at uMotif
Featuring
Laura Gunn
Laura Gunn
Managing Director at PharmStars
George Platings
George Platings
Market Development Specialist at uMotif
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: DTx last mile delivery: HCPs and Patient adoption (Part 2)

3rd February @ 10:45AM EDT

Are you struggling getting HCPs and/or patients to adopt your DTx products? Keep reading, this sprint is for you! Places are limited so apply now to join the second session of this series and discuss with other senior leaders, DTx last mile delivery.

Featuring
Katie Archer
Katie Archer
Director, Health & Welfare Benefits Design, Planning and Analysis at The Hartford
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Featuring
Katie Archer
Katie Archer
Director, Health & Welfare Benefits Design, Planning and Analysis at The Hartford
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Digital Health Solutions with the greatest impact in cancer patients' lives

8th February @ 10:45AM EDT

How can Digital Health improve cancer patients’ lives? Are you working in this industry? Keep reading, this meeting is for you. Join us as we discuss current Digital Health products in oncology and the unmet/gaps need to be addressed.

Featuring
Myles Furnace
Myles Furnace
Commercial VP, Closed Loop Medicine
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Featuring
Myles Furnace
Myles Furnace
Commercial VP, Closed Loop Medicine
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.